Market News AIOpen the app

DRUG stock news · Bright Minds Biosciences Inc.

Stories about Bright Minds Biosciences Inc. (DRUG) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for DRUG

Follow Bright Minds Biosciences Inc. (DRUG) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DRUG
Free on the App Store and Google Play, or on the web.
  1. Nov 2, 2026, 10:15 AM ET · Trial

    The FDA put a hold on Bright Minds Biosciences' new drug for kids with epilepsy, causing shares to fall 55%.

    Bad for DRUG

    The FDA paused Bright Minds’ planned U.S. BMB-101 study for pediatric epilepsy, citing mouse toxicity and missing safety data.